bioRxivCell BiologyPreprint
Pancreatic islet cell stress induced by insulin-degrading enzyme deficiency promotes islet regeneration and protection from autoimmune diabetes
S. Zhu, E. Waeckel-Enee, A. Moser, M.-A. Bessard, K. Roger, J. Lipecka, A. Yilmaz, B. Bertocci, J. Diana, B. Saintpierre, I. C. Guerrera, S. Francesconi, F.-X. Mauvais, P. van Endert
Abstract
Appropriate tuning of protein homeostasis through mobilization of the unfolded protein response (UPR) is key to the capacity of pancreatic beta cells to cope with highly variable demand for insulin synthesis. An efficient UPR ensures a sufficient beta cell mass and secretory output but can also affect beta cell resilience to autoimmune aggression. The factors regulating protein homeostasis in the face of metabolic and immune challenges are insufficiently understood. We examined beta cell adaptation to stress in mice deficient for insulin-degrading enzyme (IDE), a ubiquitous protease with high affinity for insulin and genetic association with type 2 diabetes. IDE deficiency induced a low-level UPR in both C57BL/6 and autoimmune non-obese diabetic (NOD) mice, associated with rapamycin-sensitive beta cell proliferation strongly enhanced by proteotoxic stress. Moreover, in NOD mice, IDE deficiency protected from spontaneous diabetes and triggered an additional independent pathway, conditional on the presence of islet inflammation but inhibited by proteotoxic stress, highlighted by strong upregulation of regenerating islet-derived protein 2, a protein attenuating autoimmune inflammation. Our findings establish a key role of IDE in islet cell protein homeostasis, identify a link between low-level UPR and proliferation, and reveal an UPR-independent anti-inflammatory islet cell response uncovered in the absence of IDE of potential interest in autoimmune diabetes.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defective proinsulin handling modulates the MHC I bound peptidome and activates the inflammasome in β-cells
Muhammad Saad Khilji, Pouya Faridi, … Michał Marzec·BiomedicinesPeer-reviewed·Mar 30, 2022
- The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, non-toxic concentrations of interleukin 1 b
Muhammad Saad Khilji, Danielle Verstappen, … Michał Marzec·PLoS ONEPeer-reviewed·Feb 13, 2020
- Inhibition of inositol-requiring enzyme 1 RNase activity protects pancreatic beta cell and improves diabetic condition in insulin mutation-induced diabetes
O. Herlea-Pana, V. Eeda, … W. Wang·bioRxiv·Aug 30, 2020
- Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice
C. Muralidharan, F. Huang, … R. G. Mirmira·bioRxiv·Oct 6, 2023
- Increased Inflammation as well as Decreased Endoplasmic Reticulum Stress and Translation Differentiate Pancreatic Islets of Pre-symptomatic Stage 1 Type 1 Diabetes and Non-diabetic Cases
A. C. Swensen, Paul Piehowski, … Weijun Qian·DiabetologiaPeer-reviewed·Jun 2, 2025
- Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2
T. Cremer, H. Hoelen, … E. Wiertz·PLOS ONEPeer-reviewed·May 24, 2024